Taysha Gene Therapies to Host Conference Call to Discuss Astellas Pharma’s Strategic Investment to Support the Development of Taysha’s AAV-based Gene Therapy Programs
October 24 2022 - 7:35PM
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric,
pivotal-stage gene therapy company focused on developing and
commercializing AAV-based gene therapies for the treatment of
monogenic diseases of the central nervous system (CNS) in both rare
and large patient populations, today announced that it will host a
conference call and webcast with slides to discuss Astellas
Pharma’s strategic investment to support the development of two of
Taysha’s AAV-based gene therapy programs, TSHA-102 for Rett
syndrome and TSHA-120 for giant axonal neuropathy (GAN), on
Tuesday, October 25, 2022, at 8:00 AM Eastern Time.
Conference
Call Details |
Tuesday,
October 25, at 8:00 AM Eastern Time / 7:00 AM Central
Time |
Toll Free: |
877-407-0792 |
International: |
201-689-8263 |
Conference ID: |
13734026 |
Webcast: |
https://ir.tayshagtx.com/news-events/events-presentations |
|
|
About Taysha Gene Therapies
Taysha Gene Therapies (Nasdaq: TSHA) is on a mission to
eradicate monogenic CNS disease. With a singular focus on
developing curative medicines, we aim to rapidly translate our
treatments from bench to bedside. We have combined our team’s
proven experience in gene therapy drug development and
commercialization with the world-class UT Southwestern Gene Therapy
Program to build an extensive, AAV gene therapy pipeline focused on
both rare and large-market indications. Together, we leverage our
fully integrated platform—an engine for potential new cures—with a
goal of dramatically improving patients’ lives. More information is
available at www.tayshagtx.com.
Company Contact:Kimberly Lee, D.O. Chief
Corporate Affairs OfficerTaysha Gene
Therapiesklee@tayshagtx.com
Media Contact:Carolyn HawleyEvoke
Canalecarolyn.hawley@evokegroup.com
Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Taysha Gene Therapies (NASDAQ:TSHA)
Historical Stock Chart
From Jul 2023 to Jul 2024